Medicaid does not pay for medical marijuana. Because marijuana is still a Schedule I controlled substance under federal law, no federal health program will reimburse you for cannabis products, for the doctor visit to get a recommendation, or for your state cannabis card. Medicaid can, however, cover a small group of FDA-approved prescription drugs derived from or modeled on cannabis, and a pending federal rescheduling effort may eventually shift some of this.
Why Federal Law Blocks Coverage
Two federal rules combine to shut Medicaid out. The first is the Controlled Substances Act, which lists marijuana as Schedule I, the most restrictive category and one reserved for substances the federal government treats as having high abuse potential and no accepted medical use.1Office of the Law Revision Counsel. 21 USC 812 – Schedules of Controlled Substances
The second is a coverage rule inside Medicaid itself. Under the Medicaid Drug Rebate Program, a “covered outpatient drug” has to be approved for safety and effectiveness by the FDA under the Federal Food, Drug, and Cosmetic Act.2Office of the Law Revision Counsel. 42 USC 1396r-8 – Payment for Covered Outpatient Drugs Dispensary flower, edibles, tinctures, and vape products have never gone through FDA approval. So dispensary cannabis fails on both counts: federally illegal and FDA-unapproved. CMS has said directly that medical marijuana and its derivatives cannot be covered by federal health programs because they remain illegal under federal law.
That block covers the whole chain of costs. Medicaid will not pay for the dispensary purchase, the physician visit that produces the cannabis recommendation, the state registration card, or accessories such as vaporizers. Every dollar comes out of your pocket.
Cannabis-Related Prescriptions Medicaid Can Cover
Here is where patients often get the wrong impression. Medicaid will not pay for cannabis from a dispensary, but it can pay for prescription medications made from cannabis compounds or synthetic versions of them, provided the FDA has approved the drug. A few exist right now:
- Epidiolex, a purified cannabidiol medication approved for seizures in Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex in patients age two and older. After FDA approval in 2018, the DEA placed Epidiolex in Schedule V.3Federal Register. Placement in Schedule V of Certain FDA-Approved Drugs Containing Cannabidiol
- Dronabinol, sold as Marinol and Syndros, a synthetic THC prescribed for chemotherapy-related nausea and appetite loss in AIDS patients.
- Nabilone, sold as Cesamet, a synthetic cannabinoid for chemotherapy-related nausea.4U.S. Food and Drug Administration. FDA and Cannabis: Research and Drug Approval Process
These are pharmacy prescriptions, not dispensary products. Standard Medicaid formulary rules apply, including prior authorization and any copay your state plan sets. If cannabis-based treatment is something you’re considering, ask your doctor whether one of these medications fits your condition. Many patients assume everything cannabis-related is off-limits under Medicaid and never learn these options exist.
What You’ll Pay Out of Pocket
Private insurance treats medical cannabis the same way Medicaid does, so the full cost falls on you. Expect three separate bills.
The Physician Certification
The initial visit for a cannabis recommendation typically runs $49 to $199, depending on your state and whether you use telehealth or an in-person clinic. Renewal evaluations are often cheaper. Some states require recertification every six to twelve months, so this is a recurring cost, not a one-time one.
The State Card
State registration fees range from nothing to around $200 per year. Several states offer reduced fees for veterans, seniors, or people enrolled in public assistance programs including Medicaid and SNAP. It’s worth checking your state health department’s page for the current fee and any discount you qualify for.
The Cannabis Itself
Products are the biggest ongoing expense, and prices vary widely by state, product type, and dispensary. Monthly spending typically runs $100 to $300 or more, depending on dosage and form. Some dispensaries and nonprofits offer hardship discounts or patient assistance programs for people on fixed incomes, but these are inconsistent and not guaranteed.
No Federal Tax Deduction Either
The IRS treats medical marijuana the same way Medicaid does. Publication 502 states: “You can’t include in medical expenses amounts you pay for controlled substances (such as marijuana) that aren’t legal under federal law, even if such substances are legalized by state law.”5Internal Revenue Service. Publication 502, Medical and Dental Expenses If you itemize and your total medical expenses cross the 7.5 percent adjusted gross income threshold, your cannabis spending still cannot be part of that calculation.
Other Federal Benefits That May Be At Risk
Being on Medicaid and holding a medical cannabis card does not, by itself, put your Medicaid eligibility in jeopardy. But if you rely on other federal programs, the overlap creates real problems that catch people off guard.
Federally Assisted Housing
If you live in housing that receives HUD funding, medical cannabis use is a live risk. HUD’s position is that because marijuana is illegal under the Controlled Substances Act, owners of federally assisted properties must deny admission to anyone currently using marijuana, no matter what state law says. For existing tenants, property owners have discretion to evict case by case.6U.S. Department of Housing and Urban Development. Use of Marijuana in Multifamily Assisted Properties A valid state card provides no protection. Some property managers look the other way; they are not required to.
SNAP
SNAP benefits cannot be used to buy any cannabis-derived product, including foods or drinks that contain marijuana. The USDA has told retailers that accepting SNAP for these products is a program violation that can lead to disqualification, monetary penalties, and criminal prosecution.7Food and Nutrition Service / U.S. Department of Agriculture. SNAP Retailer Notice: Cannabis-Derived Products are NOT Eligible for SNAP Purchase Holding a medical cannabis card doesn’t affect your SNAP eligibility, but the benefits will not fund cannabis purchases in any form.
Employment
Federal law does not protect medical cannabis patients from being fired or turned down for a job after a positive drug test. Courts in multiple states have upheld employer drug-free workplace policies even in states where medical marijuana is legal. Some states have enacted their own employment protections for cardholders, but coverage varies widely and many states offer none. If your employer tests, a card is not a shield.
Will Federal Rescheduling Change This
In December 2025, a presidential executive order directed the Attorney General to complete the rulemaking to move marijuana from Schedule I to Schedule III “in the most expeditious manner” federal law allows.8The White House. Increasing Medical Marijuana and Cannabidiol Research The proposed rule had drawn nearly 43,000 public comments and was awaiting an administrative law hearing as of that date.
Moving marijuana to Schedule III would remove the “illegal under federal law” barrier, but the FDA-approval requirement inside Medicaid would still stand.2Office of the Law Revision Counsel. 42 USC 1396r-8 – Payment for Covered Outpatient Drugs Dispensary products still would not be FDA-approved for specific medical conditions. The nearer-term effect of rescheduling would be on research and on the development of new FDA-approved cannabis-based drugs, which could then enter Medicaid formularies through the normal pathway. For now, both locks remain in place, and the answer for your dispensary receipts stays no.